All clinical trials are reviewed by an Institutional Review Board (IRB) to protect the rights and safety of people who join. But some trials stand out because they’re doing more for patients. Our review committee of patients and researchers helped identify some trials that are going above and beyond. They are our featured trials.
- Allogeneic (cells from a donor) blood or marrow transplant (BMT) with an unrelated mismatched donor and post-transplant cyclophosphamide (PTCy) to treat blood cancers in children and adultsTo find out if allogeneic BMT with an unrelated mismatched donor and PTCy is safe and works well to treat blood cancers in children and adults